Socioeconomic status and breast cancer treatment Marie S. DreyerAnn B. NattingerLiliana E. Pezzin Review 07 September 2017 Pages: 1 - 8
Molecular profile of atypical hyperplasia of the breast David N. Danforth Review Open access 14 September 2017 Pages: 9 - 29
Inverse relationship between Ki67 and survival in early luminal breast cancer: confirmation in a multivariate analysis Alberto GallardoBarbara Garcia-ValdecasasEnrique Lerma Preclinical study 01 September 2017 Pages: 31 - 37
Tumour-infiltrating lymphocytes (TILs)-related genomic signature predicts chemotherapy response in breast cancer Mariko KochiTakayuki IwamotoToshiyoshi Fujiwara Preclinical study 13 September 2017 Pages: 39 - 47
Highly sensitive detection of ESR1 mutations in cell-free DNA from patients with metastatic breast cancer using molecular barcode sequencing Nanae MasunagaNaofumi KagaraShinzaburo Noguchi Preclinical study 13 September 2017 Pages: 49 - 58
Outcome after neoadjuvant chemotherapy in estrogen receptor-positive and progesterone receptor-negative breast cancer patients: a pooled analysis of individual patient data from ten prospectively randomized controlled neoadjuvant trials Marion T. van MackelenberghCarsten DenkertSibylle Loibl Clinical trial 05 September 2017 Pages: 59 - 71
An observational study investigating failure of primary endocrine therapy for operable breast cancer in the elderly Robert ThomasRachel RowellHenry Cain Clinical trial 06 September 2017 Pages: 73 - 80
Durable complete response in HER2-positive breast cancer: a multicenter retrospective analysis Naoki NiikuraAkihiko ShimomuraHhiroji Iwata Clinical trial 11 September 2017 Pages: 81 - 87
Impact of histopathology, tumor-infiltrating lymphocytes, and adjuvant chemotherapy on prognosis of triple-negative breast cancer Roberto A. Leon-FerreMei-Yin PolleyMatthew P. Goetz Clinical trial 14 September 2017 Pages: 89 - 99
Characteristics and prognosis of breast cancer after liver or kidney transplantation I-Ji JeongSung-Gyu LeeHee Jeong Kim Clinical trial 15 September 2017 Pages: 101 - 106
Tumor and serum DNA methylation in women receiving preoperative chemotherapy with or without vorinostat in TBCRC008 Roisin M. ConnollyMary Jo FacklerSaraswati Sukumar Clinical trial 16 September 2017 Pages: 107 - 116
Registry study to assess hair loss prevention with the Penguin Cold Cap in breast cancer patients receiving chemotherapy Brooke A. RiceElizabeth S. Ver HoeveMichelle E. Melisko Clinical trial 18 September 2017 Pages: 117 - 122
Immunohistochemical versus molecular (BluePrint and MammaPrint) subtyping of breast carcinoma. Outcome results from the EORTC 10041/BIG 3-04 MINDACT trial G. VialeF. A. de Snoofor the MINDACT investigators Clinical trial 19 September 2017 Pages: 123 - 131
Obesity, physical activity, and breast cancer survival among older breast cancer survivors in the Cancer Prevention Study-II Nutrition Cohort Maret L. MaliniakAlpa V. PatelMia M. Gaudet Epidemiology 31 August 2017 Pages: 133 - 145
Non-visualized sentinel nodes in breast cancer patients; prevalence, risk factors, and prognosis N. C. VerheuvelA. C. VoogdR. M. H. Roumen Epidemiology Open access 31 August 2017 Pages: 147 - 156
Chronic pain and other symptoms among breast cancer survivors: prevalence, predictors, and effects on quality of life Rola HamoodHatem HamoodLital Keinan-Boker Epidemiology 31 August 2017 Pages: 157 - 169
Healthy lifestyle impact on breast cancer-specific and all-cause mortality Adaline E. HeitzRichard N. BaumgartnerStephanie D. Boone Epidemiology 31 August 2017 Pages: 171 - 181
Association of the severity of diabetes-related complications with stage of breast cancer at diagnosis among elderly women with pre-existing diabetes Ebtihag O. AlenziS. Suresh MadhavanXi Tan Epidemiology 02 September 2017 Pages: 183 - 193
Second opinion strategies in breast pathology: a decision analysis addressing over-treatment, under-treatment, and care costs Anna N. A. TostesonQian YangDonald L. Weaver Epidemiology 06 September 2017 Pages: 195 - 203
Severe depression more common in patients with ductal carcinoma in situ than early-stage invasive breast cancer patients M. L. GregorowitschH. J. G. D. van den BongardH. M. Verkooijen Epidemiology Open access 11 September 2017 Pages: 205 - 213
Healthcare utilization, Medicare spending, and sources of patient distress identified during implementation of a lay navigation program for older patients with breast cancer Gabrielle B. RocqueCourtney P. WilliamsElizabeth A. Kvale Epidemiology 12 September 2017 Pages: 215 - 223
Take care of your neighborhood Elmer E. HuertaPatricia Weeks-CoulthurstSandra M. Swain Epidemiology 12 September 2017 Pages: 225 - 234
Weight gain in hormone receptor-positive (HR+) early-stage breast cancer: is it menopausal status or something else? Kirsten A. NyropAllison M. DealShlomit S. Shachar Epidemiology 14 September 2017 Pages: 235 - 248
Exome array analysis identifies ETFB as a novel susceptibility gene for anthracycline-induced cardiotoxicity in cancer patients Sara Ruiz-PintoGuillermo PitaAnna González-Neira Epidemiology 14 September 2017 Pages: 249 - 256
Does levonorgestrel-releasing intrauterine system increase breast cancer risk in peri-menopausal women? An HMO perspective Nava Siegelmann-DanieliItzhak KatzirYossef Lomnicky Epidemiology Open access 14 September 2017 Pages: 257 - 262
The expected benefit of preventive mastectomy on breast cancer incidence and mortality in BRCA mutation carriers, by age at mastectomy Vasily GiannakeasSteven A. Narod Epidemiology 15 September 2017 Pages: 263 - 267
Concordance analysis of paired cancer antigen (CA) 15-3 and 27.29 testing David C. LinJonathan R. Genzen Epidemiology 19 September 2017 Pages: 269 - 276
Obesity and survival in the neoadjuvant breast cancer setting: role of tumor subtype in an ethnically diverse population Ying L. LiuAnurag SarafKevin Kalinsky Epidemiology 25 September 2017 Pages: 277 - 288
Multidimensional phenotyping of breast cancer cell lines to guide preclinical research Jodi M. SaunusChanel E. SmartSunil R. Lakhani Brief Report Open access 09 September 2017 Pages: 289 - 301
Predictive role of loco-regional radiotherapy among metastatic breast cancer patients who had undergone primary tumor surgery Kadri Altundag Letter to the Editor 05 September 2017 Pages: 303 - 303
A frameshift mutation in BRCA1 leads to hereditary breast and ovarian cancer in one part of a family and to familial pancreatic cancer in another Laura GieldonJohannes WagnerAndreas Rump Letter to the Editor 12 September 2017 Pages: 305 - 307
1st UK Interdisciplinary Breast Cancer Symposium—15th–16th January 2018 Abstracts 10 January 2018 Pages: 309 - 405
Correction to: IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patients Carlo PalmieriRob C. SteinOn behalf of the IRIStrial participants Correction 25 October 2017 Pages: 407 - 407